Literature DB >> 28193300

Predictors of premenstrual impairment among women undergoing prospective assessment for premenstrual dysphoric disorder: a cycle-level analysis.

K M Schmalenberger1, T A Eisenlohr-Moul2, P Surana2, D R Rubinow2, S S Girdler2.   

Abstract

BACKGROUND: Women who experience significant premenstrual symptoms differ in the extent to which these symptoms cause cyclical impairment. This study clarifies the type and number of symptoms that best predict premenstrual impairment in a sample of women undergoing prospective assessment for premenstrual dysphoric disorder (PMDD) in a research setting. Central research goals were to determine (1) which emotional, psychological, and physical symptoms of PMDD are uniquely associated with premenstrual impairment, and (2) how many cyclical symptoms optimally predict the presence of a clinically significant premenstrual elevation of impairment.
METHOD: A total of 267 naturally cycling women recruited for retrospective report of premenstrual emotional symptoms completed daily symptom reports using the Daily Record of Severity of Problems (DRSP) and occupational, recreational, and relational impairment for 1-4 menstrual cycles (N = 563 cycles).
RESULTS: Multilevel regression revealed that emotional, psychological, and physical symptoms differ in their associations with impairment. The core emotional symptoms of PMDD were predictors of impairment, but not after accounting for secondary psychological symptoms, which were the most robust predictors. The optimal number of premenstrual symptoms for predicting clinically significant premenstrual impairment was four.
CONCLUSION: Results enhance our understanding of the type and number of premenstrual symptoms associated with premenstrual impairment among women being evaluated for PMDD in research contexts. Additional work is needed to determine whether cognitive symptoms should receive greater attention in the study of PMDD, and to revisit the usefulness of the five-symptom diagnostic threshold.

Entities:  

Keywords:  Impairment; menstrual cycle; premenstrual dysphoric disorder; premenstrual syndrome; women's health

Mesh:

Year:  2017        PMID: 28193300      PMCID: PMC5486218          DOI: 10.1017/S0033291716003524

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  10 in total

Review 1.  The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD).

Authors:  Uriel Halbreich; Jeff Borenstein; Terry Pearlstein; Linda S Kahn
Journal:  Psychoneuroendocrinology       Date:  2003-08       Impact factor: 4.905

Review 2.  Cognitive-behavioral and pharmacological interventions for premenstrual syndrome or premenstrual dysphoric disorder: a meta-analysis.

Authors:  Maria Kleinstäuber; Michael Witthöft; Wolfgang Hiller
Journal:  J Clin Psychol Med Settings       Date:  2012-09

3.  Daily Record of Severity of Problems (DRSP): reliability and validity.

Authors:  J Endicott; J Nee; W Harrison
Journal:  Arch Womens Ment Health       Date:  2005-09-20       Impact factor: 3.633

4.  Evaluating the criteria used for identification of PMS.

Authors:  Bonnie B Dean; Jeff E Borenstein; Kevin Knight; Kimberly Yonkers
Journal:  J Womens Health (Larchmt)       Date:  2006-06       Impact factor: 2.681

5.  Psychological intervention for premenstrual syndrome: a meta-analysis of randomized controlled trials.

Authors:  Jason W Busse; Victor M Montori; Catherine Krasnik; Irene Patelis-Siotis; Gordon H Guyatt
Journal:  Psychother Psychosom       Date:  2008-10-14       Impact factor: 17.659

6.  Criteria for premenstrual dysphoric disorder: secondary analyses of relevant data sets.

Authors:  S Ann Hartlage; Sally Freels; Nathan Gotman; Kimberly Yonkers
Journal:  Arch Gen Psychiatry       Date:  2012-03

7.  Prospective assessment of menstrually related mood disorders.

Authors:  D R Rubinow; P Roy-Byrne; M C Hoban; P W Gold; R M Post
Journal:  Am J Psychiatry       Date:  1984-05       Impact factor: 18.112

8.  The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France.

Authors:  T R Hylan; K Sundell; R Judge
Journal:  J Womens Health Gend Based Med       Date:  1999-10

9.  Premenstrual dysphoric disorder: evidence for a new category for DSM-5.

Authors:  C Neill Epperson; Meir Steiner; S Ann Hartlage; Elias Eriksson; Peter J Schmidt; Ian Jones; Kimberly A Yonkers
Journal:  Am J Psychiatry       Date:  2012-05       Impact factor: 18.112

10.  Toward the Reliable Diagnosis of DSM-5 Premenstrual Dysphoric Disorder: The Carolina Premenstrual Assessment Scoring System (C-PASS).

Authors:  Tory A Eisenlohr-Moul; Susan S Girdler; Katja M Schmalenberger; Danyelle N Dawson; Pallavi Surana; Jacqueline L Johnson; David R Rubinow
Journal:  Am J Psychiatry       Date:  2016-08-13       Impact factor: 18.112

  10 in total
  4 in total

1.  Treatment of premenstrual dysphoria with continuous versus intermittent dosing of oral contraceptives: Results of a three-arm randomized controlled trial.

Authors:  Tory A Eisenlohr-Moul; Susan S Girdler; Jacqueline L Johnson; Peter J Schmidt; David R Rubinow
Journal:  Depress Anxiety       Date:  2017-07-17       Impact factor: 6.505

Review 2.  Ovarian Hormones as a Source of Fluctuating Biological Vulnerability in Borderline Personality Disorder.

Authors:  Jessica R Peters; Tory A Eisenlohr-Moul
Journal:  Curr Psychiatry Rep       Date:  2019-10-17       Impact factor: 5.285

3.  Premenstrual Disorders: A Primer and Research Agenda for Psychologists.

Authors:  Tory Eisenlohr-Moul
Journal:  Clin Psychol       Date:  2019

4.  Grey matter correlates of affective and somatic symptoms of premenstrual dysphoric disorder.

Authors:  Inger Sundström-Poromaa; Erika Comasco; Manon Dubol; Johan Wikström; Rupert Lanzenberger; C Neill Epperson
Journal:  Sci Rep       Date:  2022-04-09       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.